PetMed Express, Inc.
PETSPetMed Express, Inc. (PETS) is a leading online pharmacy specializing in the sale of prescription and non-prescription pet medications, health products, and supplies. The company operates primarily through its website, PetMD, providing pet owners with convenient access to veterinary-approved products and advice. Established in 1996, PetMed Express focuses on delivering quality pet healthcare solutions with a focus on customer service and convenience.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 18, 2023 | $0.30 | 2023-08-11 | 2023-08-14 |
| June 12, 2023 | $0.30 | 2023-06-05 | 2023-06-06 |
| February 27, 2023 | $0.30 | 2023-02-16 | 2023-02-20 |
| November 30, 2022 | $0.30 | 2022-11-17 | 2022-11-18 |
| August 19, 2022 | $0.30 | 2022-08-11 | 2022-08-12 |
Dividends Summary
- Consistent Payer: PetMed Express, Inc. has rewarded shareholders with 58 dividend payments over the past 14 years.
- Total Returned Value: Investors who held PETS shares during this period received a total of $12.83 per share in dividend income.
- Latest Payout: The most recent dividend of $0.30/share was paid 889 days ago, on August 18, 2023.
- Yield & Schedule: PETS currently pays dividends quarterly with an annual yield of 36.09%.
- Dividend Growth: Since 2009, the dividend payout has grown by 200.0%, from $0.10 to $0.30.
- Dividend Reliability: PETS has maintained or increased its dividend for 43 consecutive payments.
Company News
Cardone Ventures submitted an unsolicited all-cash proposal of $4.25 per share to acquire PetMed Express, valuing the company at approximately $89 million. The offer targets all outstanding shares and aims to improve the pet pharmacy's performance under private ownership.
PetMeds launches a holiday product collection emphasizing pet health, wellness, and practical gifts, including grooming products, first aid kits, DNA tests, and supplements for dogs, cats, and horses.
Law firm investigating potential securities law violations by PetMed Express after delayed earnings release caused stock price to drop 11.22%.
PetMed Express is under investigation for potential financial misconduct, including delayed financial reporting, revenue recognition issues, and executive resignations after a whistleblower complaint.
PetMed Express is under investigation for potential financial reporting misconduct, including delayed financial statements, revenue recognition issues, and executive resignations.
